Novartis US Foundation

Initiatives summarizing efforts from the Novartis US Foundation.

Content from this campaign

Philanthropy

Novartis US Foundation Supports Telehealth Programs to Provide Access to Care for New Jersey’s Most Vulnerable Communities

Thursday, April 30, 2020 - 09:00

The Novartis US Foundation announced that a grant provided to the New Jersey Primary Care Association (NJPCA) made it possible to launch five new telehealth programs for community health centers in the state.

More from Novartis

Novartis Foundation Leprosy Elimination Initiative

The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...

The Novartis Malaria Initiative

For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...

Novartis – science based innovation for better patient outcomes

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novartis Access: Medicines to treat chronic diseases in lower-income countries

Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...

Novartis US Foundation commits $25M to improve health equity by reducing health disparities in the US

Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...

Novartis US Foundation

Initiatives summarizing efforts from the Novartis US Foundation.

Novartis COVID-19 Trials

Novartis clinical trial efforts in COVID-19 R&D.

Novartis US Foundation COVID-19 Response

In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...